Literature DB >> 9170832

Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans.

R I Sibley1, A F Sibley.   

Abstract

Since there is general agreement that screening for prostate cancer should be carried out, at least for high-risk individuals, there should be little debate that African-American men should be screened. Current screening guidelines include the two most cost-effective methods of early detection, digital rectal examination and prostate specific antigen. The use of transrectal ultrasound and guided biopsy improves the yield. This article reports on the findings of 50 African-American patients with prostatic carcinoma diagnosed by sonographically guided biopsy in a single, community urology practice. Overall, prostate specific antigen was elevated in 94%, digital rectal examination was positive in 60%, and transrectal ultrasound was positive in 78%. A focal hypoechoic lesion was demonstrated in 58%. When the site of tumor, as specified in the pathology report, was correlated with the findings on digital rectal examination and transrectal ultrasound, both digital rectal examination and transrectal ultrasound were positive in 45%. Transrectal ultrasound was positive when digital rectal examination was negative in 30%. Digital rectal examination was positive when ultrasound was not in 14%. Random biopsy revealed areas of carcinoma that were not detected by digital rectal examination nor ultrasound in 40%. We conclude that even though random biopsy significantly improves the detection of prostate carcinoma, sonographic guidance is beneficial to systematically biopsy the gland and to avoid omission of characteristic lesions during random samplings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9170832      PMCID: PMC2608161     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  28 in total

1.  Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers.

Authors:  C Mettlin; G Jones; H Averette; S B Gusberg; G P Murphy
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

2.  Enlargement of the pterygo-masseteric muscle complex.

Authors:  M H Morse
Journal:  Clin Radiol       Date:  1994-01       Impact factor: 2.350

3.  High 10-year survival rate in patients with early, untreated prostatic cancer.

Authors:  J E Johansson; H O Adami; S O Andersson; R Bergström; L Holmberg; U B Krusemo
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

Review 4.  Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. Overview: historical and contemporary.

Authors:  W F Whitmore
Journal:  NCI Monogr       Date:  1988

5.  Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors.

Authors:  A Villers; J E McNeal; F S Freiha; T A Stamey
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

6.  Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

Authors:  G J Miller; J M Cygan
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

7.  Screening for carcinoma of the prostate: a GP based study.

Authors:  R S Kirby; M G Kirby; M R Feneley; T McNicholas; A McLean; J A Webb
Journal:  Br J Urol       Date:  1994-07

8.  Echogenicity of prostate cancer correlated with histologic grade and stromal fibrosis: endorectal US studies.

Authors:  M D Rifkin; E T McGlynn; H Choi
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

9.  Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.

Authors:  J E McNeal; E A Redwine; F S Freiha; T A Stamey
Journal:  Am J Surg Pathol       Date:  1988-12       Impact factor: 6.394

10.  The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.

Authors:  M Ohori; T M Wheeler; J K Dunn; T A Stamey; P T Scardino
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more
  2 in total

1.  Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.

Authors:  M Sheikh; O Al-Saeed; E O Kehinde; T Sinan; J T Anim; Y Ali
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Screening for prostate cancer in African Americans.

Authors:  J W Moul
Journal:  Curr Urol Rep       Date:  2000-05       Impact factor: 2.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.